Adult T-Cell LeukemiaSymptoms, Doctors, Treatments, Advances & More
Adult T-Cell Leukemia Overview
Learn About Adult T-Cell Leukemia
View Main Condition: Leukemia
- Adult T-cell leukemia/lymphoma
- ATLL
- Adult T-cell leukaemia
- Adult T-cell leukaemia/lymphoma (HTLV-1 positive)
- Adult T-cell lymphoma
UVA Health Emily Couric Clinical Cancer Center
Thomas Loughran is a Hematologist practicing medicine in Charlottesville, Virginia. Dr. Loughran is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Adult T-Cell Leukemia, Leukemia, Agranulocytosis, and Acute Myeloid Leukemia (AML). Dr. Loughran is currently accepting new patients.
Pediatric Hematology-Oncology
Elizabeth Raetz is a Hematologist and an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Raetz is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Raetz is board certified in American Board Of Pediatrics. Dr. Raetz is currently accepting new patients.
UT MD Anderson Cancer Center
Tapan Kadia is a Hematologist practicing medicine in Cary, North Carolina. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Prolymphocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who achieve remission after CART alone, it may cure up to 50% of people who receive this therapy. However, for people who relapse after CART, it can be hard to achieve remission again. In patients where CART fails, stem cell transplant (HCT) can be used to pre...
Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center